Could poop pills improve your mental health? Alberta studies aim to find out

By Caley Gibson

Published August 13, 2024

Could taking poop pills help improve the health of those suffering from certain mental health disorders?

The University of Calgary’s Cumming School of Medicine is currently recruiting for two studies to find out whether fecal microbiota transplantation (FMT) can reduce symptoms of major depression disorder (MDD) and obsessive-compulsive disorder (OCD).

FMT is a medical procedure where a pill prepared from the stool (poop) of a healthy person is transferred into a patient’s gut. The procedure has been successful in treating C. difficile, a bacterium that causes an infection of the colon.

“Poop pills” are one way the gut microbiome can be manipulated by bringing in beneficial bacteria and reducing the number of “harmful” bacteria. According to researchers at the U of C, there is compelling evidence of an interaction between one’s gut and the central nervous system.

“Underlying our whole research is the concept that we believe that your gut bacteria via the gut-brain axis – the connection between your GI system and your brain – impact mental illness and that this is a very viable target for treatment, that mental illness is not just a brain disease, that it actually has strong links to your GI system,” explained Dr. Valerie Taylor, head of the psychiatry department at the U of C.

Taylor said there is a strong body of research identifying the fact that gut microbiome is different in people who have mental illness and those who don’t.

Share the Post:
Receive the latest news

Join Our Journey

Be the First to Know: Unlock exclusive updates on the progress and launch timeline of our groundbreaking biotherapeutics product development.

Name(Required)

Asem Bala

MSc

Asem Bala, MSc has over 20 years of experience in Healthcare & Clinical Research Management, now working at Taylored Biotherapeutics to create partnerships and ensure regulatory approvals.

Dr. Valerie Taylor

MD, PhD, FRCP

Dr. Valerie Taylor, MD, PhD, FRCP is a Professor of Psychiatry at the University of Calgary. She completed a Bachelor of Medical Science and graduated from medical school at Memorial University of Newfoundland. She subsequently finished her residency training in Psychiatry and got her PhD in Neuroscience from McMaster University in Hamilton, Ontario. Prior to coming to Calgary, she was the chief of Psychiatry at the Women’s College Hospital and the chief of Adult Health Services at the Center for Addiction and Mental Health in Toronto.

Her academic focus has been on the area of medical psychiatry – specifically, for the last 5 years, on the gut brain axis and the the gut microbiome. She is the only funded researcher in North America examining the therapeutic effects of fecal transplant as a treatment for mental health and she currently has 4 novel clinical trials looking at modifying the gut microbiome to treat mood disorders as well as the largest biological neuroscience microbiome repository in North America. She has over 180 peer reviewed publications and funding from a variety of national and international funding agencies. In 2020 she started Taylored Biotherapeutics, a micro therapeutics drug company. Today her primary role is in leading product development, getting regulatory approval, and finding partnerships.